Search

Search Results

• Proteasome inhibitors: bortezomib in multiple myeloma

  M Cavo, MC Pallotti, L Pantani, A Petrucci, A Brioli, C Terragna, N Testoni, G Marzocchi, S Durante, M Ceccolini, G Perrone, P Tacchetti, E Zamagni, P Tosi, M Baccarani

  2009-06-23

  https://doi.org/10.4081/hmr.v2i5.751

  191

  PDF: 216

• Thyrosin kinase inhibitors: nilotinib

  F Castagnetti, F Palandri, G Gugliotta, A Poerio, M Amabile, S Soverini, G Martinelli, M Baccarani, G Rosti

  2009-06-23

  https://doi.org/10.4081/hmr.v2i5.721

  384

  PDF: 455

• The road to cure in multiple myeloma: incorporation of novel agents into autologous stem cell transplantation

  M Cavo, E Zamagni, P Tacchetti, A Brioli, C Pallotti, L Pantani, M Ceccolini, A Petrucci, N Testoni, C Terragna, G Marzocchi, S Durante, P Tosi, M Baccarani

  2009-06-12

  https://doi.org/10.4081/hmr.v3i3.558

  213

  PDF: 131

• Azacytidine: first therapeutic opportunity for myelodysplastic syndromes

  C Finelli, C Bosi, G Martinelli, M Baccarani

  2009-06-08

  https://doi.org/10.4081/hmr.v2i7.415

  232

  PDF: 328